Role of Obstructive Sleep Apnea in Stroke Appearance "AVSAS"

Completed

Phase N/A Results N/A

Trial Description

Stroke is the third leading cause of death in industrialized countries and the first cause of handicap in adults. Several stroke risk factors were identified such as high blood pressure, diabetes mellitus, hypercholesterolemia or cardiac arrhythmias. Sleep respiratory disorders have been found to be frequent among patients with stroke. Among them obstructive sleep apnea (OSA) syndrome seems to be the most important due to its association with high blood pressure and atrial fibrillation.
Stroke can be responsible of central apneas, therefore the differential diagnosis between central apneas and pure OSA after stroke is sometimes difficult. The misidentification of OSA can explain the poor tolerance of CPAP treatment by these patients. The purpose of the present study is to investigate the association between pre-stroke OSA syndrome OSA diagnosed on specific scales and confirmed by polygraphic studies and stroke occurrence.

Detailed Description

• Principal Objective : Investigate the association between obstructive sleep apnea diagnosed and hemispheric ischemic stroke
• Secondary Objective :
Evaluate the relation between obstructive sleep apnea and:
- stroke mechanisms
- stroke prognosis
- post-stroke tolerance to CPAP treatment.
- Study design :
Prospective case-control study
• Inclusion criteria :
Patients (150):
Fist ischaemic hemispheric stroke or TIA Age: 50 to 90 French native speaker Able to answer the questions
Controls (600):
Age: 50 to 90 French native speaker Able to answer the questions
• Exclusion criteria : Patients Haemorrhagic stroke Stroke of the brainstem Past medical history of ischaemic stroke Dementia Confusion Unable to give his informed consent
Controls:
Past medical history of ischaemic stroke Dementia Confusion Unable to give his informed consent
• Study plan: Cases will be recruited in the stroke unit of the Pr Orgogozo at the Bordeaux University hospital. After verification of inclusion and exclusion criteria Berlin scale will be measured. A polygraphic study will be performed to patients with a Berlin scale > 2. Patients stroke characteristics will be recorded (initial severity, stroke mechanism) at baseline and stroke outcome will be evaluated at 3 months (stroke recurrence and functional outcome).
Controls will be recruited among sex and age matched patients hospitalized at the Bordeaux-University hospital for investigation of non-vascular disorder. After verification of inclusion and exclusion criteria Berlin scale will be measured. A polygraphic study will be performed to subjects with a Berlin scale > 2. Controls will be evaluated at 3 months using a phone interview
• Number of subjects : 150 cases and 600 controls

Conditions

Interventions

  • Polygraphic study Other
    Intervention Desc: Berlin scale will be measured. A polygraphic study will be performed to subjects with a Berlin scale > 2. Patients stroke characteristics will be recorded (initial severity, stroke mechanism) at baseline and stroke outcome will be evaluated at 3 months (stroke recurrence and functional outcome). Controls will be evaluated at 3 months using a phone interview
    ARM 1: Kind: Experimental
    Label: case
    Description: Fist ischaemic hemispheric stroke or TIA
    ARM 2: Kind: Experimental
    Label: control
    Description: No ischaemic hemispheric stroke or TIA

Trial Design

  • Observation: Case Control
  • Perspective: Prospective
  • Sampling: Non-Probability Sample

Trial Population

Cases will be recruited in the stroke unit at the Bordeaux University hospital Controls will be recruited among sex and age matched patients hospitalized at the Bordeaux-University hospital for investigation of non-vascular disorder

Outcomes

Type Measure Time Frame Safety Issue
Primary Stroke recurrence 3 months No
Secondary Stroke outcome (Rankin, Barthel) Stroke mechanism CPAP tolerance 3 months No

Sponsors